dc.creatorCarrillo, Ileana
dc.creatorCastillo, Christian
dc.creatorDroguett, Daniel
dc.creatorMuñoz, Lorena
dc.creatorLiempi, Ana
dc.creatorMaya Arango, Juan
dc.creatorGalanti Garrone, Norbel
dc.creatorKemmerling Weis, Ulrike
dc.date.accessioned2017-03-02T14:01:49Z
dc.date.accessioned2019-04-26T01:09:39Z
dc.date.available2017-03-02T14:01:49Z
dc.date.available2019-04-26T01:09:39Z
dc.date.created2017-03-02T14:01:49Z
dc.date.issued2016
dc.identifierPlacenta. Volumen: 45 Páginas: 95-95 Abstract de reunión: P1.75
dc.identifier1532-3102
dc.identifierhttp://repositorio.uchile.cl/handle/2250/142932
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/2446957
dc.description.abstractCongenital Chagas’ disease is caused by the haemophlagelated protozoan Trypanosoma cruzi (T. cruzi), which is able to cross the placental barrier and infect both the placenta and fetus. However, congenital transmission rates are low, suggesting the presence of local defense mechanisms. The trophoblast is the first tissue of the placental barrier in contact with the maternal blood; its epithelial turnover is considered part of innate immune system. Previous studies have shown that T. cruzi induces proliferation, differentiation and apoptosis in the trophoblast, suggesting an increase in epithelial turnover. Caspase 8 is an essential molecule not only during apoptotic cell death but also during trophoblast differentiation.
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourcePlacenta
dc.titleCaspase 8 inhibition increases the infection with trypanosoma cruzi in thehuman trophoblast cell line (bewo)
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución